La vendita allo scoperto per Synaptogenix Inc Ordinary Shares dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Synaptogenix Inc Ordinary Shares. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Synaptogenix Inc Ordinary Shares (NASDAQ:SNPX) Azioni, Report sulle vendite allo scoperto

Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) shares are trading relatively flat in the<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> premarket session on Tuesday.</a>
The company has teamed up with Tomorrow.io, a weather analytics and resilience firm, to bring AI-driven weather insights into its suite of <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46314920/palantir-and-tomorrow-io-partner-to-operationalize-global-weather-intelligence-and-agentic-ai" rel="noreferrer noopener">decision-making platforms.</a>
The collaboration targets improved operational readiness for clients in defense, aviation, government, and infrastructure by embedding real-time atmospheric data and predictive tools directly into Palantir's systems.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/biotech/25/07/46289610/palantir-co-founder-joe-lonsdale-wants-a-fda-overhaul-with-special-forces-style-ai-team-because-china-is-racing-to-outpace-us-in-biotech" rel="noreferrer noopener">Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI Team Because China Is Racing To Outpace US In Biotech</a>
The companies aim to offer fully automated, weather-aware workflows by integrating Tomorrow.io's proprietary satellite constellation and machine learning capabilities with Palantir's operational AI.
The effort will pursue joint commercial and government opportunities across sectors.
Tomorrow.io has launched the first private weather satellite network specifically designed for atmospheric observation.
Its adaptive AI models learn from each data cycle, making hyper-local, minute-by-minute forecasts possible.
By embedding these capabilities into Palantir's platforms, the joint solution aims to help users automate critical decisions—like rerouting logistics or activating emergency protocols—based on real-time weather intelligence.
As part of the arrangement, Tomorrow.io will join Palantir's FedStart initiative.
This program enables SaaS providers to rapidly enter the federal marketplace by supporting FedRAMP and IL compliance, thereby providing them access to U.S. government agencies.
Other recent FedStart partners include Anthropic, Grafana Labs, and Virtualitics.
Mike Gallagher, Palantir's Head of Defense, said the goal of FedStart is to accelerate the government&#8217;s ability to access and deploy breakthrough technologies.
"By&nbsp;enabling the federal workforce to take advantage of&nbsp;Tomorrow.io&nbsp;while ensuring strict adherence to the compliance and security&nbsp;requirements for processing U.S. government (USG) data, we are excited to help increase productivity and efficacy across&nbsp;government," Gallagher said.
Shimon Elkabetz, CEO and co-founder of Tomorrow.io, highlighted the strategic importance of the partnership. "In the age of AI, whoever owns the data owns the future," Elkabetz said. "As the only full-stack weather company with proprietary data from space, operational-grade AI modeling and agentic intelligence, we are defining the next generation of decision-making and competitive advantage with a truly synergetic partner in Palantir."
With this collaboration, the two companies plan to create tailored solutions for both public and private clients, setting a new global benchmark in resilience and real-time, data-driven action.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, PLTR stock has gained over 410% in the past year. Investors can gain exposure to the stock via GraniteShares 2x Long PLTR Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIR#NASDAQ">PTIR</a>).
Price Action: PLTR shares are trading lower by 0.15% to $139.50 premarket at last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/management/25/07/46301128/investor-used-to-believe-they-could-beat-the-market-by-picking-stocks-now-they-ask-is-holding-individual-stocks-worth-the-stress-anymore" target="_blank" rel="noreferrer noopener">Investor Used To Believe They Could Beat The Market By Picking Stocks. Now They Ask &#8216;Is Holding Individual Stocks Worth The Stress Anymore?&#8217;</a></li>
</ul>
Photo: Shutterstock

Equities

News

Markets

Movers

General

PLTR

PTIR

This Palantir Partnership Uses AI And Satellites To Predict Weather Like Never Before - Here's What It Means

Evercore ISI Group analyst Elizabeth Anderson maintains Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) with a In-Line and lowers the price target from $5 to $3.

Price Target

Analyst Ratings

Evercore ISI Group Maintains In-Line on Agilon Health, Lowers Price Target to $3

Management

OTEX

Open Text Corporation Announces Chadwick Westlake Will Step Down As CFO Effective August 15, 2025

- Alpha Modus Holdings, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>), a pioneer in AI-powered retail technology and data-driven innovation, is pleased to announce the issuance of U.S. Patent No. 12,354,121, effective July 8, 2025. This patent strengthens Alpha Modus's intellectual property position in the fast-evolving in-store technology space, particularly in areas related to real-time shopper engagement, digital signage, and autonomous retail optimization.
The patent, co-invented by Alpha Modus Director Michael Garel and Jim Wang, underscores the company's long-term commitment to advancing retail intelligence platforms that bridge the gap between physical stores and AI-driven decisioning engines.

AMOD

Alpha Modus Holdings Secures U.S. Patent No. 12,354,121 To Enhance AI-Powered Retail Technology For Real-Time Shopper Engagement And Autonomous Store Optimization

JMP Securities analyst Rustam Kanga reiterates Penguin Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) with a Market Outperform and maintains $26 price target.

Reiteration

Penguin Solutions, Inc. - Ordinary Shares

PENG

JMP Securities Reiterates Market Outperform on Penguin Solutions, Maintains $26 Price Target

GWRS

Global Water Resources Acquires Seven Water Systems At Value Equivalent To ~1.05 Times Current Rate Base Of ~$7.7M And Are Expected To Generate ~$1.5M In Revenue Annually

Top-Line Data Expected in the Fourth Quarter of 2025
CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTVA#NASDAQ">MTVA</a>),&nbsp;a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the 48 mg, multiple ascending dose (MAD) cohort of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR), for the treatment of obesity. Top-line data is expected in the fourth quarter of 2025.
The Phase 1 trial is a randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ascending doses of DA-1726 in obese, otherwise healthy subjects. The study enrolled healthy adults with a minimum body mass index (BMI) between 30 – 45 kg/m2. Nine subjects in each cohort are being randomized in a 6:3 ratio, with each subject receiving either 4 weekly administrations of DA-1726 or placebo. The primary endpoint of the Phase 1 trial was to assess the safety and tolerability of DA-1726 by monitoring adverse events (AEs), serious adverse events (SAEs), treatment emergent adverse events (TEAEs) and AEs leading to treatment discontinuation. Secondary endpoints included the PK of DA-1726, assessed via serum concentrations over time and metabolite profiling at the highest doses of DA-1726. Exploratory endpoints included the effect of DA-1726 on metabolic parameters, cardiac parameters, fasting lipid levels, body weight, waist circumference and body mass index (BMI), among others.

MTVA

MetaVia Doses First Patient In 48 Mg, MAD Cohort Of Phase 1 Clinical Trial Of DA-1726, OXM Analog Agonist That Functions As GLP1R And GCGR, For Treatment Of Obesity

Groundbreaking GPU architecture, powered by CoreWeave's AI Cloud platform, will enable enterprises and startups to push the boundaries of AI innovation
LIVINGSTON, N.J., July 9, 2025 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4464853-1&amp;h=2791177077&amp;u=http%3A%2F%2Fwww.coreweave.com%2F&amp;a=CoreWeave">CoreWeave</a>, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) ("CoreWeave"), the AI Hyperscaler&#x2122;, today announced it is the first cloud platform to make NVIDIA RTX PRO 6000 Blackwell Server Edition instances generally available.
"CoreWeave is built to move at the speed of innovation, and with the new RTX PRO 6000-based instances, we're once again first to bring advanced AI and graphics technology to the cloud," said Peter Salanki, Co-Founder and Chief Technology Officer of CoreWeave. "This is a major step forward for customers building the future of AI, as it gives them the ability to optimize and scale on GPU instances that are ideal for their applications, and a testament to the speed and reliability of our AI cloud platform."
The new RTX PRO 6000 Blackwell Server Edition achieves up to 5.6x faster LLM inference and 3.5x faster text-to-video generation than the previous generation, ideal for inference of models up to 70B parameters. By combining NVIDIA's cutting-edge compute with CoreWeave's purpose-built AI Cloud Platform, customers are able to access a more cost-efficient alternative to larger GPU clusters while maintaining strong performance for teams building and scaling AI applications.
With the launch of RTX PRO 6000, CoreWeave now offers one of the widest ranges of NVIDIA Blackwell infrastructure on the market, including the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4464853-1&amp;h=4191014761&amp;u=https%3A%2F%2Fwww.coreweave.com%2Fblog%2Fcoreweave-becomes-the-first-cloud-provider-with-generally-available-nvidia-gb200-nvl72-instances&amp;a=NVIDIA+GB200+NVL72+system">NVIDIA GB200 NVL72 system</a>&nbsp;and <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4464853-1&amp;h=1669737860&amp;u=https%3A%2F%2Fwww.coreweave.com%2Fblog%2Fcoreweave-expands-its-nvidia-blackwell-fleet-with-generally-available-nvidia-hgx-b200-instances&amp;a=NVIDIA+HGX+B200+platform">NVIDIA HGX B200 platform</a>. Whether a customer is looking to train their next trillion-parameter large language model or serve multimodal inference, CoreWeave's flexible platform and AI-optimized software stack allow customers to select the optimal Blackwell architecture for their unique needs.

CRWV

NVDA

CoreWeave Announces It Is The First Cloud Platform To Make NVIDIA RTX PRO 6000 Blackwell Server Edition Instances Generally Available

BNZI

Banzai Appoints Dean Ditto As CFO, Effective Jul. 14

Despite a 3% drop in Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) network hashrate in June, daily miner revenues soared to approximately $55,300 per exahash per second (EH/s), one of the highest profitability levels this year, according to a commentary shared with <a href="https://www.benzinga.com">Benzinga</a> by the analytics team of TeraHash, a global Bitcoin yield protocol.
What Happened: This surprising divergence, fueled by Bitcoin's $109,000 spot price and $14 billion in ETF inflows, added $5.3 billion—a 23% increase—to the market value of publicly listed mining firms.
According to a JPMorgan <a href="https://www.coindesk.com/markets/2025/07/01/bitcoin-network-hashrate-declined-in-june-as-miners-reacted-to-recent-heatwave-jpmorgan">report</a>, Bitcoin's network hashrate dropped by ~3% in June, primarily due to seasonal heat impacts on miners. 
TeraHash's team noted, "Bitcoin's computing power cooled in June, but its earnings rose," highlighting a break from the traditional "difficulty crushes profits" cycle. The key? Miners are adapting strategically.
While some chase high-performance computing (HPC) for AI infrastructure, others capitalize on operational flexibility.
Deals like CoreWeave Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) <a href="https://www.benzinga.com/markets/equities/25/06/46137965/crwv-corz-potential-deal-could-unlock-2-8-billion-hidden-value-for-bitcoin-miner-says-morgan-stanley">acquisition</a> of Core Scientific Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) value mining infrastructure at 16x next year's earnings, reflected a pivot to AI.
Meanwhile, a quieter segment earns through grid curtailment payments, hash rate hedging, and leasing idle capacity to retail users.
Looking forward, TeraHash models two scenarios: "Miners integrating grid programs and derivatives can reallocate ~10% of capacity and sustain margins," even as mining difficulty rises.
Conversely, HPC-heavy miners risk 15% margin compression if AI demand slows or infrastructure lags.
See Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/07/46314880/soundhoud-ai-stock-jumps-amid-ai-push-but-this-technical-indicator-signals-slowdown-and-reversal-in-rally">SoundHound AI Stock Jumps Amid AI Push, But This Technical Indicator Signals Slowdown And Reversal In Rally</a>
Why It Matters: "The market is no longer paying for raw output," the team told <a href="https://www.benzinga.com">Benzinga</a>, urging investors to back miners who "flex power deals, hedges, and capacity rentals."
This shift signals a new era for Bitcoin mining, where adaptability trumps computational power.
As miners navigate seasonal challenges and market dynamics, their ability to diversify revenue streams will define success in a rapidly evolving industry.
Price Action: As of the publication of this article, Bitcoin was trading at $109,072.24 per coin. Here&#8217;s a list of a few Bitcin ETFs that investors could consider.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Bitcoin-Linked ETFs</td>
<td>YTD Performance</td>
<td>One-Year Performance</td>
</tr>
<tr>
<td>iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>)</td>
<td>11.65%</td>
<td>87.56%</td>
</tr>
<tr>
<td>Fidelity Wise Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>)</td>
<td>11.64%</td>
<td>87.71%</td>
</tr>
<tr>
<td>Bitwise Bitcoin ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>)</td>
<td>11.66%</td>
<td>88%</td>
</tr>
<tr>
<td>Invesco Galaxy Bitcoin ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BTCO#BATS">BTCO</a>)</td>
<td>11.63%</td>
<td>87.68%</td>
</tr>
<tr>
<td>Grayscale Bitcoin Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#NYSE">GBTC</a>)</td>
<td>10.92%</td>
<td>66.78%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Wednesday. The SPY was up 0.22% at $621.73, while the QQQ advanced 0.19% to $553.39, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46313514/warren-buffetts-quiet-dividend-play-9-high-yield-stocks-held-by-a-berkshire-subsidiary" target="_blank" rel="noreferrer noopener">Warren Buffett's Quiet Dividend Play: 9 High-Yield Stocks Held By A Berkshire Subsidiary</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. 
Image Credit: Imagn

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

Invesco Galaxy Bitcoin ETF Invesco Galaxy Bitcoin ETF

BTCO

Core Scientific, Inc. - Class A Common Stock

CORZ

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

Bitcoin Miners Rake In $55K Daily Despite Heat-Driven Hashrate Dip — Here's Their Secret

IQSTEL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQST#NASDAQ">IQST</a>), a leading global telecommunications and technology company, is pleased to announce a significant reduction of $6.9 million in debt from its balance sheet, marking a strategic milestone in the company's ongoing financial strengthening and long-term growth plan.
This debt reduction will have a direct and positive impact on the company's net stockholders' equity, which stood at $11.34 million as of Q1 2025. The reduction was achieved through a combination of debt conversions into common shares and Series D Preferred Shares. The conversion into Series D Preferred Shares reflects investor confidence in IQSTEL's strategic plan to reach $1 billion in annual revenue by 2027.
In addition to improving the company's capital structure, this transaction provides $0.92 million in interest savings, directly enhancing IQSTEL's cash flow and operational flexibility.

IQST

IQSTEL Reduces Debt By $6.9M, Boosting Q1 2025 Net Equity To $11.34M And Secures $0.92M In Interest Savings Amid Strategic Growth Plan Toward $1B Revenue by 2027

KBSX

FST To Expand Fulfillment Center In Garden Grove, California

The Malian government is reportedly moving to sell $107 million worth of seized gold from Barrick Mining's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/B#NYSE">B</a>) Loulo-Gounkoto mine complex to fund the site's restart following a nearly six-month <a target="_blank" href="https://www.benzinga.com/markets/commodities/25/06/45969041/barricks-top-gold-mine-placed-under-state-control" rel="noreferrer noopener">suspension of operations</a>.
According to sources cited <a target="_blank" href="https://www.reuters.com/world/africa/mali-plans-sell-gold-reserves-barrick-complex-fund-operations-2025-07-08/" rel="noreferrer noopener">by</a> Reuters, court-appointed administrator Soumana Makadji plans to sell one metric ton of stored gold to cover essential expenses, including salaries, fuel, and contractor payments.
The development follows a prolonged escalation between the leading gold miner and Mali's military-led government. The conflict began after Mali implemented a new mining code in 2023, seeking <a target="_blank" href="https://www.benzinga.com/news/24/07/39732127/barrick-gold-navigates-new-mining-code-political-changes-to-secure-mali-operations" rel="noreferrer noopener">higher royalties from foreign miners</a>.
Barrick refused to adopt the changes, citing violations of existing mining conventions. In response, the government blocked gold exports in late 2024 and requested a court-appointed administrator, a move formalized last month.
"The state has not acted in good faith," Barrick CEO Mark Bristow said. "We will use every legal measure at our disposal to hold the state and the individuals involved accountable for these unlawful actions."
Loulo-Gounkoto, located in western Mali near the Senegal border, is one of Africa's largest gold operations and was among Barrick's top-performing assets, contributing 578,000 ounces in 2024 (roughly 15% of the company's annual production) before its suspension.
The site has nearly 20 million ounces in reserves, but with all-in-sustaining costs totaling about $100 million per quarter, the administrator's decision to sell the gold is unsurprising. However, the government's capability to operate such a project is debatable.
Bristow expressed skepticism, warning that such an endeavor could lead to "severe damage to the long-term prospects of the mine." Sources familiar with the matter stated that it could take at least four months to restore normal production levels and likely much longer under provisional state management due to the absence of skilled expatriate staff and the disruption of critical systems.
According to the latest update, Barrick has <a target="_blank" href="https://www.barrick.com/English/news/news-details/2025/barrick-holding-firm-through-ICSID-arbitration-amid-malian-court-ruling/default.aspx" rel="noreferrer noopener">confirmed</a> that the arbitration process with the International Centre for Settlement of Investment Disputes is now fully underway.
The company has requested provisional measures to prevent further escalation and safeguard its legal rights.
Mali's changes to the mining code have negatively contributed to the country's output. The country produced 51 metric tons of gold in 2024, representing a <a target="_blank" href="https://www.benzinga.com/news/global/25/02/43588936/malian-gold-output-falls-23-as-new-mining-law-pressures-producers" rel="noreferrer noopener">23% decline</a> from the 66.5 tons produced in 2023.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46305321/copper-price-surges-trump-tariffs-stocks-july-2025" target="_blank" rel="noreferrer noopener">Copper Rallies To Record Highs After Trump's 50% Tariff Bombshell: What's Moving Markets Tuesday?</a></li>
</ul>
Photo by Below the Sky via Shutterstock

Commodities

Media

Mali To Finance Barrick's Mine Restart By Selling Seized Gold

ADIL

Adial Pharmaceuticals Files PCT Patent Application To Extend IP Exclusivity On Core Technology To At Least 2045

Morgan Stanley analyst Joseph Moore maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Underweight and raises the price target from $68 to $74.

Morgan Stanley Maintains Underweight on Teradyne, Raises Price Target to $74

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial&nbsp;
Recent EU approval from the European Medicines Agency (EMA) boosts trial profile
Enrollment in Part A of MIRACLE reaches seven subjects treated and one additional subject in screening
16 additional clinical sites in Europe and the US expected to begin recruitment by the end of August; building to an expected 30 plus sites for Part A of MIRACLE
Anticipated data readout of Part A remains in 2H 2025
HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced that the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in the country of Georgia has approved its Clinical Trial Application (CTA) to conduct its pivotal Phase 2B/3, multi-center, randomized, double-blind, placebo-controlled, adaptive design study of Annamycin in combination with cytarabine (also known as "Ara-C" and for which the combination of Annamycin and Ara-C is referred to as "AnnAraC") for the treatment of adult patients with acute myeloid leukemia (AML) who are refractory to or relapsed (R/R) after induction therapy (R/R AML). This Phase 3 "MIRACLE" trial (derived from Moleculin R/R AML AnnAraC Clinical Evaluation) is a global approval trial, including sites in the US, Europe and the Middle East. Additionally, the Company expects the first patient to be treated in Georgia to occur by the end of August, if not sooner.

Biotech

MBRX

Moleculin Biotech Secures Georgian Regulation Agency for Medical and Pharmaceutical Activities Approval For Phase 2B/3 MIRACLE AML Trial; European Medicines Agency Boosts Profile As Enrollment Expands To 30+ Sites With Data Readout Expected In 2H 2025

Elon Musk's SpaceX is gearing up for a jaw-dropping $400 billion valuation in its <a href="https://www.benzinga.com/news/space/25/07/46312510/elon-musks-spacex-insider-share-sale-could-push-valuation-to-400-billion-starlink-is-the-rocket-fuel">latest insider share sale</a>. But if you're not an employee, investor, or close friend of the rocket maker, you're probably stuck on the sidelines. 
SpaceX's tender offer allows employees and early investors to cash out their shares at soaring prices, but public access remains tightly locked down. This latest $400 billion valuation is a reminder of how out of reach these mega-privates have been.
Read Also: <a href="https://www.benzinga.com/news/politics/25/07/46307371/musk-vs-trump-tesla-ceo-is-down-87-billion-in-2025-but-still-worth-49x-more-than-trump-media-trump-coin">Musk Vs. Trump: Tesla CEO Is Down $87 Billion In 2025 But Still Worth 49X More Than Trump Media &amp; Trump Coin</a>
<h2 class="wp-block-heading">OpenAI, SpaceX, Epic — Now in Your Pocket</h2>
Enter SoFi Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) &#8211; quietly giving retail investors a rare shot at owning pieces of SpaceX, OpenAI, Epic Games, and other private giants, starting with just 10 bucks.
SoFi's <a href="https://investors.sofi.com/news/news-details/2025/SoFi-Expands-Access-to-Private-Markets-with-Funds-from-Cashmere-Fundrise-and-Liberty-Street-Advisors/default.aspx">new funds</a>, backed by Cashmere, Fundrise, and Liberty Street Advisors, bundle private market opportunities into accessible portfolios inside the SoFi app. Retail investors can enter with a minimum investment as low as $10, gaining exposure to high-growth companies previously reserved for Silicon Valley insiders and large funds.
<h2 class="wp-block-heading">The Democratization Of Billion-Dollar Bets</h2>
With late-stage private valuations skyrocketing and IPOs staying frozen, these curated funds may be the only way regular investors can snag a slice of tomorrow's tech titans today. 
It's a democratization of access, making previously rarefied opportunities practical for anyone with a smartphone and a few bucks to spare.
<h2 class="wp-block-heading">Why It Matters</h2>
While SpaceX's $400 billion valuation dominates headlines, the real story might be SoFi quietly rewriting the rules of private market investing.
For investors eager to ride the next wave of innovation without the billionaire-only price tag, the door just cracked wide open.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46186180/raoul-pal-says-robinhood-letting-users-trade-openai-spacex-through-blockchain-is-democratization-of-finance-end-of-public-vs-private-markets-has-begun">Raoul Pal Says Robinhood Letting Users Trade OpenAI, SpaceX Through Blockchain Is &#8216;Democratization Of Finance&#8217; — End Of Public Vs Private Markets Has Begun</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Long Ideas

Tech

Trading Ideas

SOFI

Can't Buy SpaceX Stock? SoFi Just Opened The Backdoor — And It Starts At $10

Dave Ramsey, a renowned personal finance expert, has shared his views on the prioritization of 401(k) plans over college funds. He believes that saving for retirement should take precedence over saving for a child&#8217;s college education.
What Happened: Ramsey, in an email to TheStreet, emphasized the importance of prioritizing retirement savings over college funds. He stated that while saving for a child&#8217;s college education is a noble endeavor, it should not take precedence over retirement savings, <a href="https://www.thestreet.com/retirement/dave-ramsey-sends-strong-message-to-americans-on-401-k-plans?ref=biztoc.com">reported</a> TheStreet.
&#8220;Setting&nbsp;aside a college fund for&nbsp;your kids is a really&nbsp;nice thing to do, if&nbsp;you can actually afford that&nbsp;kind of thing,&#8221; Ramsey wrote. &#8220;But&nbsp;kids can also further their&nbsp;education by getting good grades,&nbsp;applying for scholarships, choosing a&nbsp;school they can afford and&nbsp;working their tails off while&nbsp;attending classes.&#8221;
Ramsey also emphasized the various ways to obtain a college degree without relying on parents&#8217; savings. He then stressed the necessity of retirement savings, stating that everyone will eventually retire, unless they pass away before reaching retirement age.
He also stressed the need for early financial preparation for retirement. Ramsey advocates for saving as much as possible to ensure a comfortable life during the golden years.
Ramsey addressed the financial constraints some parents face, stating that not being able to contribute to a child&#8217;s education &#8220;doesn't make them bad parents.&#8221; Ramsey is a strong advocate for Roth IRAs as a preferred investment vehicle, citing their flexibility and long-term benefits.
SEE ALSO: <a href="https://benzinga.com/news/politics/25/07/46312553/trump-thanks-ron-desantis-florida-lawmakers-for-renaming-4-mile-stretch-near-mar-a-lago-donald-j-tr" target="_blank" rel="noreferrer noopener">Trump Thanks Ron DeSantis, Florida Lawmakers for Renaming 4-Mile Stretch Near Mar-a-Lago &#8216;Donald J. Trump Boulevard,&#8217; Calls It a &#8216;Wonderful Honor&#8217;</a>
Why It Matters: Ramsey&#8217;s views on retirement savings and college funds are consistent with his previous statements on financial planning. In a recent article, Ramsey encouraged parents to set realistic boundaries for their children&#8217;s college education. He advised against taking out <a href="https://www.benzinga.com/personal-finance/management/25/07/46279015/dave-ramsey-encourages-parents-to-get-honest-about-what-they-can-afford-for-their-chi">student loans</a> if parents cannot afford their children&#8217;s tuition.
Earlier this year, Ramsey also criticized workers who abandoned their<a href="https://www.benzinga.com/personal-finance/financial-advisors/25/05/45187836/dave-ramsey-blasts-budget-slackers-who-bail-on-401ks-during-market-turmoil-shortterm-temper-tantrums"> 401(k) plans</a> during market turmoil. He stressed the importance of a disciplined financial approach and the need to prioritize retirement savings.
However, Ramsey&#8217;s advice has not always been well-received. In a separate incident, he advised a 28-year-old caller against draining her 401(k) and IRA for a <a href="https://www.benzinga.com/personal-finance/25/05/45424768/28-year-old-refuses-to-sell-crypto-but-wants-to-drain-her-401k-and-ira-for-a-750k-house-dave-ramsey-tells-her-youre-too-broke">house purchase</a>. His advice was met with criticism from some who felt it did not consider the caller&#8217;s individual circumstances.
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/personal-finance/management/25/07/46263095/my-bodys-getting-achier-every-day-disabled-veteran-with-7500-monthly-income-and-no-savings-should-he-retire-or-wait-3-more-years">&#8216;My Body&#8217;s Getting Achier Every Day&#8217;: Disabled Veteran With $7,500 Monthly Income And No Savings — Should He Retire Or Wait 3 More Years?</a> </li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Dave Ramsey Warns Americans Against Prioritizing Kids' College Funds Over 401(k)s — Says It Doesn't Make You 'Bad Parents'

Morgan Stanley analyst Joshua Pokrzywinski maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Equal-Weight and raises the price target from $700 to $725.

Morgan Stanley Maintains Equal-Weight on Parker Hannifin, Raises Price Target to $725

Sernova Biotherapeutics ("Sernova") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SVA#TSX">SVA</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/SEOVF#OTCQB">SEOVF</a>) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) to evaluate Eledon's immunosuppressive agent tegoprubart (AT-1501) in Sernova's ongoing Phase 1/2 clinical trial of its Cell Pouch Bio-hybrid Organ in patients with type 1 diabetes (T1D).
Under the terms of the agreement, Eledon will supply tegoprubart, an investigational anti-CD40L antibody being evaluated for its potential to prevent transplant rejection in islet cell, kidney and xeno transplantation, will be used in place of tacrolimus in the upcoming Cohort C of Sernova's Phase 1/2 clinical trial. Tacrolimus is currently a standard immunosuppressive drug used in organ transplantation to prevent rejection. However, its potential toxicity, particularly toward insulin-producing beta cells, and its side effect profile limit its suitability as an optimal immunosuppressive agent for islet cell therapy in T1D.
In an investigator-initiated study led by Dr. Piotr Witkowski, a leading expert in islet transplantation at the University of Chicago, T1D patients received islet transplants along with tegoprubart to prevent rejection. Three participants achieved normal, stable blood sugar levels and became insulin independent. Islet engraftment, measured by graft function standardized to the number of islets infused, was three to five times higher than in comparable subjects outside this study who received tacrolimus-based immunosuppression, suggesting treatment with tegoprubart better protects transplanted islets resulting in improved graft survival and function. Treatment was generally well tolerated in all subjects with no unexpected adverse events or severe hypoglycemic episodes.

ELDN

SEOVF

TSX:SVA

Eledon And Sernova Collaborate To Test Tegoprubart As Safer Immunosuppressant In Sernova's Phase 1/2 Cell Pouch Trial For Type 1 Diabetes

Press Releases

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Offerings

Synaptogenix Announces $5.0 Million Financing

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength

Small Cap

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token

Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking

Comments

Synaptogenix Inc Ordinary Shares

Vendite allo scoperto

Synaptogenix Inc Ordinary Shares (NASDAQ:SNPX) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO